Timothy Trysla

Timothy Trysla

Alston & Bird

Contact

Readers' Choice Awards

Healthcare
Healthcare
Healthcare
Healthcare
View Bio
RSS

Latest Publications

Share:

Health Care Week In Review: House Passes the SUPPORT Act and Lower Cost, More Transparency Act, HHS Releases Final Rule on Health...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/18/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medicare , Pharmaceutical Industry , Prescription Drugs

Health Care Week in Review: House E&C Committee Held Mark-Up of 44 Bills, Biden Administration Announced Actions to Lower...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/11/2023  /  Animal Drugs , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medicaid , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs

Health Care Week in Review: House E&C Subcommittee on Health Held a Hearing on Healthcare and AI; CMS Extended the Application...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

12/4/2023  /  Artificial Intelligence , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare , Life Sciences , Medical Devices , OIG , Popular , SAMHSA

Health Care Week in Review: Biden Signs “Laddered” Continuing Resolution; House E&C Subcommittee Advances 21 Healthcare Bills

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

11/20/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicaid , Medicare , Prescription Drugs

Health Care Week In Review: Senate Finance Committee Advanced Bipartisan Healthcare Legislation, CMS Released Medicare Advantage...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

11/13/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Hospitals , Medicare , Medicare Advantage , Medicare Part D , Mental Health , Pharmaceutical Industry , Popular , Prescription Drugs , SAMHSA

Health Care Week in Review: CMS Releases Three Major Medicare Final Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

11/6/2023  /  21st Century Cures Act , Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , DEA , Department of Health and Human Services (HHS) , Final Rules , Health Care Providers , Healthcare Facilities , Medicaid , Medicare , National Institute of Health (NIH) , OIG , Physician Medicare Reimbursements , Popular , Prescription Drugs

Health Care Week in Review: New House Speaker Elected; HRSA Issued a Notice on 340B Drug Pricing Program Requirements

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

10/30/2023  /  Centers for Medicare & Medicaid Services (CMS) , Controlled Substances , DEA , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Hospitals , HRSA , Medicaid , Medicare , Pharmaceutical Industry , Popular , Prescription Drugs , Section 340B

Health Care Week in Review: House Energy and Commerce Subcommittee on Health Held Hearing on Medicare Proposals, CMS Released 2024...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

10/23/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicare , Medicare Part D , National Institute of Health (NIH) , Pharmaceutical Industry , Prescription Drugs

Health Care Week in Review: CMS Releases Updates on Center for Medicare and Medicaid Innovation Center (CMMI) Initiatives to...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

10/16/2023  /  American Hospital Association , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Digital Health , Drug Pricing , Drug Testing , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Hospitals , Medicaid , Medicare , Pharmaceutical Industry

Health Care Week in Review: Rep. McCarthy Ousted as Speaker of the House; CMS Announces Drug Manufacturer Participation in...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

10/9/2023  /  Abbreviated New Drug Application (ANDA) , Centers for Medicare & Medicaid Services (CMS) , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Medicare Part D , National Institute of Health (NIH) , Nursing Homes , OIG , Pharmaceutical Industry , Prescription Drugs

Health Care Week in Review: Government Shutdown in Sight, CBO Releases Report on CMMI’s Effect on Federal Spending

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

10/2/2023  /  Centers for Medicare & Medicaid Services (CMS) , Cybersecurity , Department of Health and Human Services (HHS) , Food Allergies , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medical Devices , Mental Health , National Institute of Health (NIH) , Pharmaceutical Patents , Prescription Drugs

Health Care Week in Review: CMS Issues Final Rule on Medicare Savings Program, Senate Considers Primary Care and Healthcare...

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/25/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Workers , HRSA , Medicare , Prescription Drugs , SAMHSA

Health Care Week In Review: Senators Introduced the Bipartisan Primary Care and Health Workforce Act

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/18/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , Medicare , Pharmaceutical Industry , Popular , Prescription Drugs

Health Care Week In Review: Lower Cost, More Transparency Act Draft Health Bill Released

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/11/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , HRSA , National Institute of Health (NIH) , Nursing Homes , OIG

Health Care Week In Review: HHS Selects the First 10 Drugs for Medicare Drug Price Negotiation

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

9/6/2023  /  AHRQ , Biologics , Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Long Term Care Facilities , Medicare , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , Prescription Drugs , Skilled Nursing Facility

Health Care Week in Review: CMS Announces Details to Pay Drug Costs on Installment Plan

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/29/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , HRSA , Medicare , Medicare Part D , Pharmaceutical Industry , Popular , Prescription Drugs , Vaccinations

Health Care Week in Review: Medicaid Managed Care Plans Inquiry Announced

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/21/2023  /  Centers for Medicare & Medicaid Services (CMS) , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Hospitals , Medicaid , Medicare , Prescription Drugs

Health Care Week In Review: HHS Awards $218 Million in Grant Funding

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/14/2023  /  Clinical Trials , DEA , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicare , National Institute of Health (NIH) , Nurses , OCR , Prescription Drugs , Substance Abuse

Health Care Week In Review: CMS Releases SNF and IPPS Final Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/7/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Facilities , Medicare , Skilled Nursing Facility

Health Care Week In Review: Biden Administration Releases Rules and Awards for Rural Residency Programs

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

8/1/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medicare , Pharmaceutical Industry , Prescription Drugs , Substance Abuse

Health Care Week in Review: PAHPA Reauthorization Bills Receive House and Senate Markups

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/24/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare Workers , Infectious Diseases , Medicaid , Medicare , Mental Health , OIG , Popular , SAMHSA , Substance Abuse

Health Care Week In Review: CMS and HHS Issue Proposed Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/17/2023  /  Centers for Medicare & Medicaid Services (CMS) , Child Care , Clinical Trials , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Healthcare , Healthcare Facilities , Medicaid , Medicare , OPPS , Popular

Health Care Week in Review: Leqembi Approval, Administration Issues Proposed Rules

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/10/2023  /  Centers for Disease Control and Prevention (CDC) , Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Insurance , HRSA , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , Prescription Drugs , Section 340B

Health Care Week in Review: IRA Guidance and ESRD PPS Rule

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

7/3/2023  /  Centers for Medicare & Medicaid Services (CMS) , Department of Health and Human Services (HHS) , Drug Pricing , Food and Drug Administration (FDA) , Health Care Providers , Pharmaceutical Industry , Popular , Prescription Drugs

Health Care Week in Review: Emerging Technology Coverage Pathway, Long COVID Advisory

Below is Alston & Bird’s Health Care Week in Review, which provides a synopsis of the latest news in health care regulations, notices, and guidance; federal legislation and congressional committee action; reports, studies,...more

6/26/2023  /  Centers for Medicare & Medicaid Services (CMS) , Coronavirus/COVID-19 , Department of Health and Human Services (HHS) , Food and Drug Administration (FDA) , Health Care Providers , Medical Devices , National Institute of Health (NIH) , Pharmaceutical Industry , Popular , SAMHSA
300 Results
 / 
View per page
« Previous
Page: of 12
Next »

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
Sign up Log in
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
- hide
- hide